DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Young G, Liesner R, Chang T. , et al.
A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors.
Blood 2019;
134 (24) 2127-2138
We do not assume any responsibility for the contents of the web pages of other providers.